Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guidant (GDT) -- Ignore unavailable to you. Want to Upgrade?

To: Lighthouse who wrote (195)	4/26/2002 11:18:03 AM
From: Lighthouse	Read Replies (1) \| Respond to of 235

"Guidant was awarded $158 million in damages plus interest and costs. The arbitration panel also granted an injunction against the sale of Medtronic AVE rapid exchange products in the United States. The Medtronic AVE products in dispute are not currently on the market because of a previous successful patent infringement suit brought by Boston Scientific." Well a back of the envelope calculation now put GDT's balance sheet at net cash neutral - for the first time in quite a while. (We were $175 M in the hole on March 31, 2002). Cheers,